ZLD Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$175,000.00
Insider Selling (Last 12 Months): A$0.00

Zelira Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Zelira Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zelira Therapeutics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for ZLD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Zelira Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2022Harry KarelisInsiderBuy6,250,000A$0.03A$175,000.00
11/17/2021Harry KarelisInsiderExpiry6,000,000A$0.04A$228,000.00
8/11/2020Richard HopkinsInsiderIssued1,000,000A$0.05A$50,000.00
1/2/2020Oludare OdumosuInsiderIssued35,116,656A$0.06A$1,966,532.74
See Full Table
Did Biden Bet the Future of America on the "Lithium Triangle"?
FREE investor's report details the plan to cut more ties with China and how it could create the next boom for early investors. But you must act fast.
Discover the one company set to break China's grip

SEC Filings (Institutional Ownership Changes) for Zelira Therapeutics (ASX:ZLD)

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of various medical conditions in Australia. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. The company also provides OTC products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as ITURA, an advanced relief cream formula that targets multi-symptoms, such as numbness and tingling, muscle cramps, insensitivities, and pain associated with Peripheral Artery Disease and diabetes. Zelira Therapeutics has strategic partnerships with Curtin University; the Telethon Kids Institute; the University of Western Australia; St. Vincent's Hospital; and the Children's Hospital of Philadelphia. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia.
Read More on Zelira Therapeutics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

311,821 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Zelira Therapeutics?

Zelira Therapeutics' top insider investors include:
  1. Harry Karelis (Insider)
Learn More about top insider investors at Zelira Therapeutics.
Did Biden Bet the Future of America on the "Lithium Triangle"?
FREE investor's report details the plan to cut more ties with China and how it could create the next boom for early investors. But you must act fast.
Discover the one company set to break China's grip